Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.07 USD | -2.88% | +7.62% | +24.13% |
17/05 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
13/05 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.13% | 19Cr | |
+10.79% | 12TCr | |
+11.65% | 11TCr | |
-6.20% | 2.39TCr | |
-3.58% | 2.16TCr | |
-11.28% | 1.9TCr | |
-40.50% | 1.7TCr | |
-13.41% | 1.63TCr | |
+6.64% | 1.41TCr | |
+31.84% | 1.2TCr |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Transcript : Capricor Therapeutics, Inc., Q3 2020 Earnings Call, Nov 12, 2020